2 August 2024
Weil Advises Avista and Wellspring in Acquisition of vH essentials from Wisconsin Pharmacal
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Parness Lead | Weil | Partner | Private Equity | Not stated |
| Alexander Miachika | Weil | Counsel | Private Equity | Not stated |
| Luisa Perez | Weil | Associate | Private Equity | Not stated |
| Anthony Tulipano | Weil | Associate | Private Equity | Not stated |
| Brayden Ringel | Weil | Associate | Private Equity | Not stated |
| Helyn Goldstein | Weil | Partner | Tax | Not stated |
| Josh Schonfeld | Weil | Associate | Tax | Not stated |
| Andrew Yoon | Weil | Partner | Banking & Finance | Not stated |
| Dylan Scher | Weil | Associate | Banking & Finance | Not stated |
| Dan Cruickshank | Weil | Associate | Banking & Finance | Not stated |
| Olivia Greer | Weil | Other | U.S. Privacy & Cybersecurity | Not stated |
| Dennis Adams | Weil | Partner | Technology & IP Transactions | Not stated |
| Shannon Coffey | Weil | Associate | Technology & IP Transactions | Not stated |
| Colleen Seidel | Weil | Associate | Technology & IP Transactions | Not stated |
| Brendan McNerney | Weil | Associate | Technology & IP Transactions | Not stated |
| John O'Loughlin | Weil | Partner | Regulatory Transactions | Not stated |
| Christina Carone | Weil | Associate | Regulatory Transactions | Not stated |
| John Scribner | Weil | Partner | Antitrust | Not stated |
| Michael Naughton | Weil | Counsel | Antitrust | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Wisconsin Pharmacal Company (Sell-side)